Decision-making Processes among Prostate Cancer Survivors with Rising PSA Levels

Abstract

Background Prostate cancer survivors with a rising prostate specific antigen (PSA) level have few treatment options, experience a heightened state of uncertainty about their disease trajectory that might include the possibility of cancer metastasis and death, and often experience elevated levels of distress as they have to deal with a disease they thought they had conquered. Guided by self-regulation theory, the present study examined the cognitive and affective processes involved in shared decision making between physician and patients who experience a rising PSA after definitive treatment for prostate cancer. Methods In-depth interviews were conducted with 34 prostate cancer survivors who had been diagnosed with a rising PSA (i.e., biochemical failure) within the past 12 months. Survivors were asked about their experiences and affective responses after being diagnosed with a rising PSA and while weighing potential treatment options. In addition, patients were asked about their decision-making process for the initial prostate cancer treatment. Results Compared to the initial diagnosis, survivors with a rising PSA reported increased negative affect following their diagnosis, concern about the treatability of their disease, increased planning and health behavior change, heightened levels of worry preceding doctor’s appointments (especially prior to the discussion of PSA testing results), and a strong reliance on physicians’ treatment recommendations. Conclusions Prostate cancer survivors’ decision-making processes for the treatment of a rising PSA are markedly different from those of the initial diagnosis of prostate cancer. Because patients experience heightened distress and rely more heavily on their physicians’ recommendations with a rising PSA, interactions with the health care provider provide an excellent opportunity to address and assist patients with managing the uncertainty and distress inherent with rising PSA levels.

Improving shared decision-making in chronic lymphocytic leukemia through multidisciplinary education

“…wanted detailed information shared about options [10]. In prostate cancer patients deciding between treatment and observation, patients identified the importance of the physician in making this decision [11]. There are few data on decision-making for patients with hematologic cancers.…”

The Impact of Perceived Etiology, Treatment Type, and Wording of Treatment Information on the Assessment of Gastritis Treatments

“…Patients who suffered from a myocardial infarction and attributed their heart attack to bad habits reported more lifestyle and nutrition changes after 6 months (18). What is particularly relevant here is that such causal attributions are not only modifiable (19) but also susceptible to experimental manipulation: Ogden and Jubb (1) used vignettes that either emphasized psychological or biomedical causes of several diseases. They found that treatments that were congruent to the causes were considered to be more effective.…”

Safe or Sorry? Cancer Screening and Inductive Risk

“…The quality of life for men treated for prostate cancer may be decreased, because standard treatment for prostate cancer involves removal of the prostate, which may cause incontinence or impotence, or "chemical castration" (the administration of hormones) which causes weight gain (cf. Shen et al 2015). These costs of screening would be invisible if five-year survival rates were used as a measure of the relative effectiveness of prostate cancer screening.…”